Test Information

	January 13, 2021	ARUP’s COVID-19 Convalescent Plasma Research Moves Forward in Four Clinical Trials ARUP and University of Utah Health continue to research the safety and efficacy of COVID-19
Stew and Becky Tribe hold their newborn son, Woodward, who was the first baby in Utah to be diagnosed with GAMT deficiency through Utah’s newborn test panel. Utah is one of only three states that include this screening for newborns.	January 11, 2021	ARUP-Developed Newborn Test Dramatically Changes Baby’s Life—But It Almost Didn’t Happen… Utah added screening for GAMT deficiency to its NBS panel in 2015, becoming the first state
	January 7, 2021	ARUP Expert Joins Industry Peers to Explore How COVID-19 Has Accelerated Diagnostic Innovation Which types of innovation, adaptation, and acceleration happened in diagnostic technology companies in the
	January 6, 2021	ARUP Releases Comprehensive New Resource to Help Clinicians Choose the Right Tests or… To assist clinicians in providing the best possible care for patients with thyroid
	January 4, 2021	Webinar Available for Free Continuing Education Credit Answers SARS-CoV-2 Testing Questions A recording of an hour-long webinar updating the status of diagnostic testing for SARS-CoV-2
	December 30, 2020	ARUP Researchers Played Key Role in Newborn Screening That Identified Baby Born with GAMT Deficiency In December 2020, Utah’s Newborn Screening Program identified the first patient with guanidinoacetate